The identification of Ro 31-8220 in our screen for compounds that affect nuclear foci demonstrates an important role for this compound on both MBNL- and CELF1-dependent events in DM, highlighting it as a good starting point for a drug discovery programme. The gene discussed is CELF1; the disease is diabetes mellitus.